RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
Pharmaceutical & Healthcare Annual Deals Analysis 2011
Mar 2011 - 107 pages - $3,500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010
Jan 2011 - 80 pages - $1,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010
Aug 2010 - 76 pages - $1,500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2010
May 2010 - 68 pages - $1,000
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2010
Oct 2010 - 68 pages - $1,000
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – November 2010
Nov 2010 - 67 pages - $1,000
Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, June 2011
Jun 2011 - 69 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Development phase
Registered del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription
Therapeutic target
Alzheimer's disease
Amyotrophic Lateral Sclerosis (Lou Gehri
Creutzfeldt-Jakob disease
Dementia
Multiple sclerosis
Parkinson's disease

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us